Perrigo To Pay Attorney Fees In Imodium Trial; McNeil Patents Still “Obvious”
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals does not have to pay attorney fees to Perrigo in the firms' Imodium Advanced patent claims case, according to a federal appellate court ruling issued Aug. 1
You may also be interested in...
Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team
Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team
Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team